Q3 2021 13F Holders as of 30 Sep 2021
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
3.18M
-
Number of holders
-
98
-
Total 13F shares, excl. options
-
42.1M
-
Shares change
-
-2.51M
-
Total reported value, excl. options
-
$419M
-
Value change
-
-$28M
-
Put/Call ratio
-
2.14
-
Number of buys
-
46
-
Number of sells
-
-47
-
Price
-
$9.96
Significant Holders of Passage BIO, Inc. - Common Stock, par value $0.0001 per share (PASG) as of Q3 2021
116 filings reported holding PASG - Passage BIO, Inc. - Common Stock, par value $0.0001 per share as of Q3 2021.
Passage BIO, Inc. - Common Stock, par value $0.0001 per share (PASG) has 98 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 42.1M shares
.
Largest 10 shareholders include ORBIMED ADVISORS LLC (6.96M shares), FMR LLC (5.63M shares), FRAZIER MANAGEMENT LLC (5.01M shares), Versant Venture Management, LLC (4.96M shares), BlackRock Inc. (3.12M shares), New Leaf Venture Partners, L.L.C. (2.5M shares), VANGUARD GROUP INC (1.98M shares), BOXER CAPITAL, LLC (1.93M shares), HIGHLINE CAPITAL MANAGEMENT, L.P. (1.19M shares), and MORGAN STANLEY (1.14M shares).
This table shows the top 98 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.